Cargando…
Skin rash associated with intravitreal bevacizumab in a patient with macular choroidal neovascularization
PURPOSE: The purpose of this observational case report is to describe a case of skin rash after intravitreal use of bevacizumab. METHODS: A 50-year-old man with choroidal neovascularization in the right eye due to age-related macular degeneration was treated with three intravitreal injections of bev...
Autores principales: | Ladas, Ioannis D, Moschos, Marilita M, Papakostas, Thanos D, Kotsolis, Athanasios I, Georgalas, Ilias, Apostolopoulos, Michail |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708991/ https://www.ncbi.nlm.nih.gov/pubmed/19668556 |
Ejemplares similares
-
Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin(®)) for AMD followed by controlateral sympathetic ophthalmia
por: Brouzas, Dimitrios, et al.
Publicado: (2009) -
Photodynamic therapy of choroidal neovascularization with enlargement of the spot size to include the feeding complex
por: Georgalas, Ilias, et al.
Publicado: (2009) -
Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe?
por: Karagiannis, Dimitrios A, et al.
Publicado: (2009) -
Bevacizumab (Avastin(®)) for the management of anterior chamber neovascularization and neovascular glaucoma
por: Brouzas, Dimitrios, et al.
Publicado: (2009) -
Intravitreal Bevacizumab for Choroidal Neovascular Membrane in Macular Telangiectasia Type 2
por: Gonzalez Martinez, Orlando G, et al.
Publicado: (2023)